Chemistry: analytical and immunological testing – Involving diffusion or migration of antigen or antibody
Reexamination Certificate
2006-06-13
2006-06-13
Chin, Christopher L. (Department: 1641)
Chemistry: analytical and immunological testing
Involving diffusion or migration of antigen or antibody
C422S051000, C422S051000, C422S051000, C422S051000, C422S067000, C435S013000, C435S007920, C435S287200, C435S287700, C435S287800, C435S287900, C435S970000, C435S975000, C435S805000, C435S810000, C436S169000, C436S518000, C436S525000, C436S530000, C436S531000, C436S534000, C436S536000, C436S538000, C436S541000, C436S808000, C436S810000, C436S815000, C436S816000, C436S901000
Reexamination Certificate
active
07060505
ABSTRACT:
An assay device and method are provided which allow the determination of the presence or absence of at least one analyte in a test sample, while providing specific identification of the test subject. The assay device includes a reaction medium having at least one reaction zone and at least one control zone, which is capable of providing a pattern suitable for identifying the test subject. The pattern suitable for identifying the test subject is preferably a fingerprint. In a preferred embodiment of the invention, the reaction zone and the control zone include at least one member of a ligand/receptor pair.
REFERENCES:
patent: 3784358 (1974-01-01), Drake, Jr.
patent: 4632901 (1986-12-01), Valkirs et al.
patent: 4717656 (1988-01-01), Swanljung
patent: 4774192 (1988-09-01), Terminiello et al.
patent: 4775636 (1988-10-01), Moeremans et al.
patent: 4810630 (1989-03-01), Craig et al.
patent: 4826759 (1989-05-01), Guire et al.
patent: 4853335 (1989-08-01), Olsen et al.
patent: 4883764 (1989-11-01), Kloepfer
patent: 4959324 (1990-09-01), Ramel et al.
patent: 4963325 (1990-10-01), Lennon et al.
patent: 5006464 (1991-04-01), Chu et al.
patent: 5028535 (1991-07-01), Buechler et al.
patent: 5071746 (1991-12-01), Wilk et al.
patent: 5079029 (1992-01-01), Saunders
patent: 5079172 (1992-01-01), Hari et al.
patent: 5104619 (1992-04-01), de Castro et al.
patent: 5221627 (1993-06-01), Grigg et al.
patent: 5244815 (1993-09-01), Guirguis
patent: 5270167 (1993-12-01), Francoeur
patent: 5308580 (1994-05-01), Clark
patent: 5342645 (1994-08-01), Eisele et al.
patent: 5378492 (1995-01-01), Mashiko
patent: 5416000 (1995-05-01), Allen et al.
patent: 5441698 (1995-08-01), Norell
patent: 5468648 (1995-11-01), Chandler
patent: 5629164 (1997-05-01), Rivers
patent: 5869345 (1999-02-01), Chandler
patent: 5876926 (1999-03-01), Beecham
patent: 0200381 (1986-11-01), None
patent: 0200381 (1986-11-01), None
patent: 0203238 (1986-12-01), None
patent: 0203238 (1986-12-01), None
patent: 0440350 (1991-08-01), None
patent: 0440350 (1991-08-01), None
G.G. Graham, “Noninvasive Chemical Methods Of Estimating Pharmacokinetic Parameters”, Pharmac. Ther. vol. 18, 1982, pp. 333-349.
W.A. Ritschel et al., “Monitoring Of Drug Concentrations In Saliva: A Non-Invasive Pharmacokinetic Procedure”, 1983,Exptl. Clin. Pharmacol, vol. 5, pp. 511-525.
Charles W. Gorodetzky et al., “Validity Of Screening Methods For Drugs of Abuse In Biological Fluids”, Jan. 14, 1974, Clinical Pharmacology And Therapeutics, pp. 579-587.
Edward J. Cone, “Testing Human Hari For Drugs Of Abuse. I. Individual Dose And Time Profiles Of Morphine and Codeine In Plasma, Saliva, Urine, And Beard Compared To Drug-Induced Effects On Pupils And Behavior”,Journal Of Analytical Toxicology, vol. 14, Jan./Feb. 1990, pp. 1-7.
Edward J. Cone et al., “Correlation Of Saliva Cocaine Levels With Plasma Levels And With Pharmacologic Effects After Intravenous Cocaine Administration In Human Subjects”,Journal of Analytical Toxicology, vol. 12, Jul./Aug. 1988, pp. 200-206.
John P. Nielson et al., “A Processing Protocol For Drug Residue And Latent Print Evidence”, Journal of Forensic Sciences, JFSCA, vol. 33, No. 6, Nov. 1988, pp. 1463-1472.
The Fischer Catalog, Fischer Scientific, 1990.
Richard Leute, PhD et al., “Spin Immunoassay of Opiate Narcotics in Urine and Saliva”, JAMA The Journal Of The American Medical Association, vol. 221, No. 11, Sep. 11, 1972, pp. 1231-1234.
Harold W. Peel et al., “Detection Of Drugs in Saliva of Impaired Drivers”, Journal of Forensic Sciences, JFSCA, vol. 29, No. 1, Jan. 1984, pp. 185-189.
O.R. Idowu et al., “A Review Of The Use Of Saliva In The Forensic Detection Of Drugs And Other Chemicals”, JFSS Commentary, Journal Of The Forensic Science Society 1982, vol. 22, pp. 123-135.
Loren K. Thompson et al., “Confirmation Of Cocaine In Human Saliva After Intravenous Use”,Journal Of Analytical Toxicology, vol. 11, Jan./Feb. 1987, pp. 36-38.
“Secretion”, Chpater 44, General Considerations, pp. 680-695.
Edward J. Cone et al., “Prolonged Occurrence Of Cocaine In Human Saliva And Urine After Chronic Use”,Journal Of Analytical Toxicology, vol. 13, Mar./Apr. 1989, pp. 65-68.
Eugene D. Jacobson, “Salivary Secretion”,Gastrointestinal Physiology, Chapter 6, pp. 46-54.
Schramm et al., “An Ultrafiltrate of Saliva Collected in Situ As A Biological Sample For Diagnostic Evaluation”,Clinical Chemistry, vol. 37, No. 1, 1991, pp. 114-115.
Edward J. Cone et al., “Stability Of Cocaine In Saliva”,Clinical Chemistry, vol. 34, No. 7, 1988, p. 1508.
Wolff et al., “Methadone In Saliva”,Clinical Chemistry, vol. 37, No. 7, 1991, pp. 1297-1298.
Sasaki Akira et al., “Ink-Free Fingerprint Recording Films”, The American Chemical Society,Chemical Abstracts, vol. 108, No. 8, Feb. 22, 1988, p. 66.
Akira et al., “Ink-Free Fingerprint Recording Films,”The American Chemical Society, Chemical Abstracts, vol. 108(8) p. 66 (1988).
Cone et al., “Correlation Of Saliva Cocaine Levels With Plasma Levels And With Pharmacologic Effects After Intravenous Cocaine Administration In Human Subjects,”Journal of Analytical Toxicology, vol. 12, pp. 200-206 (1988).
Cone, “Testing Human Fair For Drugs of Abuse. I. Individual Dose And Time Profiles Of Morphine And Codeine In Plasma, Saliva, Urine, And Beard Compared to Drug-Induced Effects On Pupils And Behavior,”Journal of Analytical Toxicology, vol. 14, pp. 1-7 (1990).
Cone et al., “Prolonged Occurrence Of Cocaine In Human Saliva And Urine After Chronic Use,”Journal of Analytical Toxicology, vol. 13, pp. 65-68 (1989).
Cone et al., “Stability Of Cocaine In Saliva,”Clinical Chemistry, vol. 34(7), p. 1508 (1988).
Gorodetzky et al., “Validity Of Screening Methods For Drugs Of Abuse In Biological Fluids,”Clinical Pharmacology and Therapeutics, pp. 579-587 (1974).
Graham, G.G., “Noninvasive Chemical Methods Of Estimating Pharmacokinetic Parameters,”Pharmac. Ther., vol. 18, pp. 333-349 (1982).
Idowu et al., “A Review Of The Use Of Saliva In The Forensic Detection Of Drugs And Other Chemicals,”JFSS Commentary, Journal of the Forensic Science Society, vol. 22, pp. 123-135 (1982).
Jacobson, E.D., “Salivary Secretion,”Gastrointestinal Physiology, Chapter 6, pp. 46-54.
Leute, Ph.D. et al., “Spin Immunoassay Of Opiate Narcotics In Urine And Saliva,”JAMA The Journal of the American Medical Association, vol. 221(11), pp. 1231-1234 (1972).
Nielson et al., “A Processing Protocol For Drug Residue and Latex Print Evidence,”Journal of Forensic Sciences, JFSCA, vol. 33(6), pp. 1463-1472 (1988).
Peel et al., “Detection Of Drugs In Saliva Of Impaired Drivers,”Journal of Forensic Sciences, JFSCA, vol. 29(1); pp. 185-189 (1984).
Ritschel et al., “Monitoring Of Drug Concentrations In Saliva: A Non-Invasive Pharmacokinetic Procedure,”Exptl. Clin. Pharmacol., vol. 5, pp. 511-525 (1983).
Schramm et al., “An Ultrafiltrate Of Saliva Collected In Situ As A Biological Sample For Diagnostic Evalution,”Clinical Chemistry, vol. 37(1), pp. 114-115 (1991).
“Secretion,” Chapter 44, General Considerations, pp. 680-695.
The Fisher Catalog, Fisher Scientific (1990).
Thompson et al., “Confirmation Of Cocaine In Human Saliva After Intravenous Use,”Journal of Analytical Toxicology, vol. 11, pp. 36-38 (1987).
Wolff et al., “Methadone In Saliva,”Clinical Chemistry, vol. 37(7), pp. 1297-1298 (1991).
Chin Christopher L.
La Mina, Inc.
Rothwell Figg Ernst & Manbeck P.C.
LandOfFree
Assay device does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Assay device, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Assay device will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3695370